A Randomized Study of Haploidentical Lymphocytes With Nivolumab and Intermediate Dose Cytarabine Versus Nivolumab and Intermediate Dose Cytarabine as Consolidation Treatment in Older Adults With Acute Myeloid Leukemia.
Phase of Trial: Phase II
Latest Information Update: 29 Dec 2017
At a glance
- Drugs Cytarabine (Primary) ; Nivolumab (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 29 Dec 2017 New trial record